Linked Life Data

21502354

Source:http://linkedlifedata.com/resource/pubmed/id/21502354

Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
8
pubmed:dateCreated
2011-5-17
pubmed:abstractText
Recent concerns have been raised about the risk of gallbladder disease associated with the use of drospirenone, a fourth-generation progestin used in oral contraceptives. We conducted a study to determine the magnitude of this risk compared with other formulations of oral contraceptives.
pubmed:commentsCorrections
http://linkedlifedata.com/resource/pubmed/commentcorrection/21502354-10198779, http://linkedlifedata.com/resource/pubmed/commentcorrection/21502354-10203075, http://linkedlifedata.com/resource/pubmed/commentcorrection/21502354-11578152, http://linkedlifedata.com/resource/pubmed/commentcorrection/21502354-18037932, http://linkedlifedata.com/resource/pubmed/commentcorrection/21502354-18056625, http://linkedlifedata.com/resource/pubmed/commentcorrection/21502354-19146363, http://linkedlifedata.com/resource/pubmed/commentcorrection/21502354-19679614, http://linkedlifedata.com/resource/pubmed/commentcorrection/21502354-20736474, http://linkedlifedata.com/resource/pubmed/commentcorrection/21502354-21930751, http://linkedlifedata.com/resource/pubmed/commentcorrection/21502354-3948473, http://linkedlifedata.com/resource/pubmed/commentcorrection/21502354-7166683, http://linkedlifedata.com/resource/pubmed/commentcorrection/21502354-8041531, http://linkedlifedata.com/resource/pubmed/commentcorrection/21502354-8342719, http://linkedlifedata.com/resource/pubmed/commentcorrection/21502354-9757954
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
AIM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
May
pubmed:issn
1488-2329
pubmed:author
pubmed:issnType
Electronic
pubmed:day
17
pubmed:volume
183
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
899-904
pubmed:dateRevised
2011-10-25
pubmed:meshHeading
pubmed-meshheading:21502354-Adult, pubmed-meshheading:21502354-Androstenes, pubmed-meshheading:21502354-Cholecystectomy, pubmed-meshheading:21502354-Confidence Intervals, pubmed-meshheading:21502354-Contraceptives, Oral, Combined, pubmed-meshheading:21502354-Contraceptives, Oral, Hormonal, pubmed-meshheading:21502354-Contraceptives, Oral, Synthetic, pubmed-meshheading:21502354-Desogestrel, pubmed-meshheading:21502354-Ethinyl Estradiol, pubmed-meshheading:21502354-Female, pubmed-meshheading:21502354-Gallbladder Diseases, pubmed-meshheading:21502354-Humans, pubmed-meshheading:21502354-Levonorgestrel, pubmed-meshheading:21502354-Progestins, pubmed-meshheading:21502354-Proportional Hazards Models, pubmed-meshheading:21502354-Retrospective Studies, pubmed-meshheading:21502354-Risk, pubmed-meshheading:21502354-Risk Factors
pubmed:year
2011
pubmed:articleTitle
Oral contraceptives and the risk of gallbladder disease: a comparative safety study.
pubmed:affiliation
Department of Medicine, Faculty of Medicine, University of British Columbia, Vancouver, BC. mahyar.etminan@vch.ca
pubmed:publicationType
Journal Article, Comparative Study, Research Support, Non-U.S. Gov't